MedPath

Methadone Hydrochloride

These highlights do not include all the information needed to use METHADONE HYDROCHLORIDE TABLETS for oral suspension safely and effectively.  See full prescribing information for METHADONE HYDROCHLORIDE TABLETS for oral suspension.  METHADONE HYDROCHLORIDE tablets for oral suspension, USP CII Initial U.S. Approval: 1947

Approved
Approval ID

c54baaee-8ea4-45f5-a5c8-bb84cf86832f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 12, 2021

Manufacturers
FDA

VistaPharm, Inc.

DUNS: 116743084

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Methadone Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66689-898
Application NumberANDA075082
Product Classification
M
Marketing Category
C73584
G
Generic Name
Methadone Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateNovember 8, 2021
FDA Product Classification

INGREDIENTS (5)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
METHADONE HYDROCHLORIDEActive
Quantity: 40 mg in 1 1
Code: 229809935B
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Methadone Hydrochloride - FDA Drug Approval Details